Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Inflammatory Breast Neoplasms × Enzyme-Linked Immunosorbent Assay × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Rectal Neoplasms 1 Inflammatory Breast Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms 1

Interventions

poly ICLC 1 Magnetic Resonance Spectroscopy 1 Flow Cytometry 1 Enzyme-Linked Immunosorbent Assay 1 89Zr-bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00986609 2018-07-23

MUC1 Vaccine for Triple-negative Breast Cancer

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡